The mammalian cochlea contains two types of mechanosensory hair cell that have different and critical functions in hearing. Inner hair cells (IHCs), which have an elaborate presynaptic apparatus, signal to cochlear neurons and communicate sound information to the brain. Outer hair cells (OHCs) mechanically amplify sound-induced vibrations, providing enhanced sensitivity to sound and sharp tuning. Cochlear hair cells are solely generated during development, and hair cell death-most often of OHCs-is the most common cause of deafness. OHCs and IHCs, together with supporting cells, originate in embryos from the prosensory region of the otocyst, but how hair cells differentiate into two different types is unknown 1-3 . Here we show that Insm1, which encodes a zinc finger protein that is transiently expressed in nascent OHCs, consolidates their fate by preventing trans-differentiation into IHCs. In the absence of INSM1, many hair cells that are born as OHCs switch fates to become mature IHCs. To identify the genetic mechanisms by which Insm1 operates, we compared the transcriptomes of immature IHCs and OHCs, and of OHCs with and without INSM1. In OHCs that lack INSM1, a set of genes is upregulated, most of which are normally preferentially expressed by IHCs. The homeotic cell transformation of OHCs without INSM1 into IHCs reveals a mechanism by which these neighbouring mechanosensory cells begin to differ: INSM1 represses a core set of early IHC-enriched genes in embryonic OHCs and makes them unresponsive to an IHC-inducing gradient, so that they proceed to mature as OHCs. Without INSM1, some of the OHCs in which these few IHC-enriched transcripts are upregulated transdifferentiate into IHCs, identifying candidate genes for IHC-specific differentiation.
Fig. 1 | Conditional ablation of Insm1 in hair cells results in IHC-like cells in place of
OHCs. a, Wild-type (WT), floxed (F) and conditionally deleted (cKO) alleles of Insm1. Co-expression with Cre recombinase generates an Insm1 knockout allele lacking its coding sequence (CDS) and 3′ untranslated region (UTR), leaving only part of the 5′UTR. Purple triangles, LoxP sites; red triangles, Frt sites. b-d, Hearing tests (b, c, mean with all values; d, mean ± s.e.m.). ABR thresholds (b), DPOAE thresholds (c), and iso-input functions (d) for the DPOAE of Atoh1 Cre/+ ;Insm1 F/F mice at P25-31 (black; n = 3 males and 2 females) and control littermates (red; n = 4 Insm1 F/F and 4 Atoh1 Cre/+ ;Insm1 F/+ ; 6 males and 2 females). Up arrow (c) indicates that maximum sound was insufficient to reach threshold. e-l, Immunohistochemistry in organs of Corti revealed that the Atoh1 Cre/+ ;Insm1 F/F mice had normal IHCs but many OHCs expressed calmodulin and not oncomodulin (e, f, h), had stereocilliary bundles resembling those of IHCs (f-actin labelled with phalloidin; e, f), expressed VGLUT3 instead of prestin (g; asterisk, one rare cell expressed both), had cell shapes (h) and large nuclei like IHCs (i, j, asterisks). j, Number of nuclei measured for each cell type are indicated under each data set. k, oc-IHCs had nuclear CtBP2 and a number of presynaptic ribbons (ribeye) approaching that of IHCs. l, In Atoh1 Cre/+ ;Insm1 F/F mice, oc-IHCs are more frequent in the first row of OHCs (closer to the IHCs) than the second or third rows. Data from two males, three females and seven undetermined (936 cells). m, n, Similar distribution of oc-IHCs in TgPax2 Cre/+ ;Insm1 F/F mice. n = 3 mice (234 cells). j, l, n, Mean ± s.e.m., one-tailed Student's t-tests, n = number of mice. Images and quantifications from mid-cochlear positions at P34 (e, g, i), P46 (f, h), P21, P23 and P46 (k), and P14 and P15 (m). Controls were Insm1 F/F (e, g, i, m) or Atoh1 Cre ;Insm1 F/+ (f, j, k) littermates. Scale bars, 10 µm. Biological replicates were used for all experiments and similar results were obtained from three or more mice per genotype. 
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OHCs express Insm1 transiently from the onset of differentiation (embryonic day 15.5 (E15.5)) to approximately postnatal day 2 (P2) 4 . Neuronal progenitors and nascent spiral ganglion neurons also express Insm1 4 . Because mice in which Insm1 is completely knocked out die embryonically by E19.5 5, 6 , we generated an allele (Insm1 F ) in which the entire coding sequence can be deleted (Fig. 1a , Extended Data Fig. 1 ). We conditionally ablated Insm1 F with Atoh1 Cre , expressed from E13.5 (three days before Insm1) and recombining in most cochlear hair cells and some supporting cells, but not in spiral ganglion neurons 7 . We also ablated Insm1 F with TgPax2 Cre , expressed earlier in the otocyst and recombining in most inner ear cells 8 . In these mice, Insm1 was ablated before its expression in OHCs (Extended Data Fig. 2 ). Both Atoh1 Cre/+ ;Insm1 F/F and TgPax2 Cre/+ ;Insm1 F/F (cKO) mice displayed alterations in auditory brainstem response (ABR) thresholds that can be accounted for by shifts in distortion product otoacoustic emissions (DPOAEs), a characteristic of OHC dysfunction ( Fig. 1b-d , Extended Data Fig. 3a, b ). In the organs of Corti of these mice, many cells in the positions of OHCs (the outer compartment) had features of IHCs. They had large stereocilia, like IHCs, and not the shorter, W-arranged stereocillia of OHCs (Fig. 1e, f) ; expressed the IHC-enriched calcium buffer calmodulin and lacked OHC-specific oncomodulin ( Fig. 1e , f, h, Extended Data Fig. 3f ); expressed the vesicular glutamate transporter 3 (VGLUT3), which is required for IHC presynaptic function, and lacked prestin, which is required for OHC electromotility (Fig. 1g, m) ; had the flask shape of IHCs rather than the cylindrical shape of OHCs; and had large nuclei, like IHCs, instead of the smaller nuclei of OHCs ( Fig. 1i , j, Extended Data Fig. 3j ). These nuclei harboured the transcription factor CtBP2, which is normally expressed in IHCs (Fig. 1k ), and the cells contained a number of presynaptic ribbon synapses (10.6 ± 2.1 (mean ± s.d.), n = 3 mice, 39 cells) closer to that found in control IHCs (16.3 ± 0.7, n = 3 littermate controls, 30 cells), instead of the smaller number found in OHCs (1.8 ± 0.2, n = 3 mice, 90 cells) ( Fig. 1k ). With rare exceptions ( Fig. 1g ), these abnormal cells displayed all IHC features examined and lacked those of OHCs, so we termed them oc-IHCs (outer compartment IHCs).
The proportion of oc-IHCs in Atoh1 Cre/+ ;Insm1 F/F mice (42.6 ± 10.9%, n = 12 mice) and TgPax2 Cre/+ ;Insm1 F/F mice (46.0 ± 5.64%, n = 3 mice) was about half, the rest appearing as OHCs. This is not due to incomplete or delayed ablation of Insm1, because we did not detect Insm1 mRNA in any OHCs of TgPax2 Cre/+ ;Insm1 F/F mice during or after the onset of expression (E16.5; Extended Data Fig. 2a , b, bottom). Notably, the oc-IHCs were more prevalent in the first hair that the Insm1 promoter (expressing GFP.Cre) was active in oc-HCs (OHCs) at E16.5 and E18.5, regardless of the presence (Insm1 GFP.Cre/+ ) or absence (Insm1 GFP.Cre/-) of INSM1. b, c, Immunohistochemistry at E16.5-P2. While Bcl11b, an immature OHC-specific transcription factor, was found in all oc-HCs from control Insm1 GFP.Cre/+ and Insm1 GFP.Cre/mice at E16.5 (b), its expression was diminished or undetectable (asterisks) in about half of oc-HCs in mice lacking INSM1 at E18.5 (b) and P2 (c). d, In situ hybridization revealed that in the absence of INSM1, a subset of oc-HCs began to express Fgf8 weakly as early as E16.5 (32.5%, 110/338 OHCs from n = 3 TgPax2 Cre/+ ;Insm1 F/F or Atoh1 Cre/+ ;Insm1 F/F mice) and strongly by E17.5-E18.5 (40%, 52/130 OHCs from n = 2 Insm1 GFP.Cre/or Atoh1 Cre/+ ;Insm1 F/F mice) and P0-P4 (46.6%, 61/131 OHCs from n = 3 TgPax2 Cre/+ ;Insm1 F/F or Atoh1 Cre/+ ;Insm1 F/F mice). e, Immunohistochemistry at P0 revealed that although in Atoh1 Cre/+ ;Insm1 F/F mice there was no HC loss and OHCs retained their characteristic inclination, their cell bodies were disorganized at the nuclear level. f, All OHCs at the bases of cochleae from Insm1 F/F mice had neuroplastin in stereocilia (visualized with phalloidin). However, some OHCs at the base of cochleae from TgPax2 Cre/+ ;Insm1 Flox/Flox mice lacked neuroplastin. g, Conversely, the oc-HCs that lacked neuroplastin expressed VGLUT3. Images are from mid (a-e) or basal (f, g) cochleae. Scale bars, 10 µm. Biological replicates were used for all experiments and similar results obtained from three or more mice per genotype. 
Letter reSeArCH cell row of the outer compartment than in the second or third rows ( Fig. 1l , n). In principle, these oc-IHCs in mature organs of Corti lacking INSM1 could be displaced IHCs, newly generated IHCs replacing lost OHCs, IHCs born in the outer compartment, or OHCs that had trans-differentiated into IHCs. They were not displaced IHCs, as the IHC row in both cKO mice had a normal arrangement and density of IHCs (Extended Data Figs. 3c, 4a). Although during normal development cochlear hair cells are all born during embryogenesis (E12-E16) 9,10 , early hair cell death can trigger the generation of hair cells from proliferating and trans-differentiating supporting cells in the first few days after birth [11] [12] [13] [14] [15] . This does not occur in the absence of INSM1, as hair cell density in the outer compartment (OHCs + oc-IHCs) was unaltered up to P34 (Extended Data Figs. 3d, e, 4b, c), whereas oc-IHCs were present well before that. Second, hair cells that are derived postnatally from supporting cells initially express SOX2 [12] [13] [14] , whereas none of the oc-IHCs of cKO pups expressed SOX2 (Extended Data Fig. 4d ). Third, some postnatally produced HCs result from proliferation of supporting cells [11] [12] [13] [14] , but none of the oc-IHCs in cKO mice derived from postnatal proliferation (Extended Data Fig. 4e ). These results show that oc-IHCs do not result from OHC death followed by replacement from displaced IHCs or postnatally generated hair cells. Instead, the oc-IHCs represent homeotic transformation (of mechanosensory OHCs into IHCs) due to a developmental defect in the generation or differentiation of OHCs. Either IHCs are generated in place of OHCs, or OHCs trans-differentiate into IHCs. We examined organs of Corti from mice with conditional (TgPax2 Cre/+ ; Insm1 F/F and Atoh1 Cre/+ ;Insm1 F/F ) or complete (Insm1 GFP.Cre/-) Insm1 knockout during late embryogenesis, when OHCs and IHCs begin to differentiate. At E16.5, all cells in the outer compartment begin to express the earliest markers of OHCs: the Insm1 promoter in Insm1 GFP.Cre/-embryos (which lack INSM1 but express GFP from the Insm1 promoter 4 ; Fig. 2a ), and BCL11B in nuclei ( Fig. 2b, c) . Whereas in control mice, BCL11B expression was maintained past birth, in embryos lacking INSM1 it subsided in nearly half of outer compartment hair cells (oc-HCs) (from E18.5 to P2; Fig. 2b , c). During the same period, many oc-HCs express the early IHC marker fgf8 (Fig. 2d ). Around birth, two additional markers begin to be expressed in control mice: neuroplastin, preferentially in OHC stereocillia 16 , and VGLUT3 in IHCs 17 . By comparison, in both cKO mice, many oc-HCs expressed VGLUT3 and not neuroplastin ( Fig. 2f, g) . Finally, although the orientation of IHCs and OHCs is maintained at birth in cKO mice, the disorganization of the OHC rows at the level of the nuclei already revealed alterations in cell shape ( Fig. 2e ). We conclude that in the absence of INSM1, oc-HCs are generated with early OHC features, but soon thereafter some of these cells lose these features, express early IHC markers, and proceed to differentiate into mature IHCs. This trans-differentiation of early OHCs into IHCs reveals that INSM1 is not required to initiate commitment to the OHC fate, but acts subsequently by preventing it from switching to that of IHCs. Insm1 acts by consolidating the OHC fate, making it permanent.
Brief expression of Insm1 is sufficient to evade phenotypic conversion (Extended Data Fig. 5 ). It appears that Insm1 locks the OHC fate during a narrow developmental period. Curiously, although KO OHCs completely lack Insm1 from their birth, fewer than half of these cells trans-differentiate into IHCs. This trans-differentiation in TgPax2 Cre/+ ;Insm1 F/F and Atoh1 Cre/+ ;Insm1 F/F mice is more frequent in hair cell rows closer to the IHCs than in those further away ( Fig. 1l, n) . This distribution reveals the existence of a gradient in the neural to abneural axis of the organ of Corti that regulates cochlear hair cell types. This gradient might induce IHC differentiation, and Representative genes are shown in parentheses. Although neonatal HCs of either type begin to show expression of some functional markers characteristic of mature cells (Otof and Slc17a8 (also known as Vglut3) in IHCs and Slc26a5 (also known as Prestin) in OHCs), the majority of hair cell type-specific genes at this early stage differ from those of the mature cells. Biological replicates were used for all experiments and similar results obtained from three or more mice per genotype. Letter reSeArCH INSM1 could act by preventing embryonic OHCs from responding to it.
In other developing cell types, INSM1 functions as a transcriptional activator or repressor [18] [19] [20] [21] [22] [23] [24] . We hypothesized that INSM1 directs OHCs to develop differentially from IHCs by activating OHC-specific genes or inhibiting IHC-specific genes. We first determined which genes were expressed in either differentiating hair cell type when Insm1 was expressed ( Fig. 3 ), and then searched for genes regulated by INSM1 in developing OHCs (Fig. 4) . For both approaches we used Insm1 GFP.Cre , in which the coding sequence of Insm1 is replaced by that of a fusion protein between GFP and the Cre recombinase, thereby serving as a reporter as well as a null allele 4, 23 . We generated Insm1 GFP.Cre/+ ; Atoh1 A1GFP/+ ;R26R tdTomato/+ mice, in which all hair cells express GFP (starting at E13.5 from Atoh1 A1GFP and, in OHCs, from Insm1 GFP.Cre ) but only OHCs also express tdTomato following Insm1 GFP.Cre expression (throughout the cochlea by E18.5 4 ; Fig. 3a, b ). We used these mice to sort OHCs and IHCs from neonatal (P0, approximately E19.5) organs of Corti (Fig. 3c ). Using fluorescence-activated cell sorting (FACS), we collected pools of RNA from IHCs and OHCs (Fig. 3d ), and then used RNA sequencing (RNA-seq) to obtain their transcriptomes (Supplementary Table 1 ). We thus identified 922 IHC-enriched genes and 676 OHC-enriched genes ( Fig. 3e , Supplementary Tables 1-3) . Among these were the 12 genes previously shown to be expressed preferentially in early IHCs or OHCs 4,17,25-29 ( Fig. 3e ), indicating that our approach detects most differentially expressed genes. One concern was whether genes that showed small differences in expression (twofold or less; for example, Zmat3), or that were detected at very low levels in one cell type only (for example, Sox18 and Msx1), were truly differentially expressed. We selected 21 transcripts (Fig. 3e ), and used quantitative PCR with reverse transcription (RT-qPCR) to test for differential expression using additional pools of RNA from IHCs and OHCs. All 21 genes were confirmed to be differentially expressed, and the differences in expression were similar whether estimated by RNAseq or RT-qPCR ( Fig. 3f ). We also confirmed differential expression of additional genes by methods not susceptible to potential artefacts of cell sorting and mRNA extraction: Bcl11b in OHCs by immunohistochemistry ( Fig. 2b) ; Insm2 in OHCs using an Insm2 LacZ mouse line ( Fig. 3e  inset) ; and other genes by in situ hybridization (ISH) as preferentially expressed in OHCs (Neurod6, Sez6l) or IHCs (Tbx2, Id4, Rprm, Smad3, Car13, Brip1, Lrrn1, Pink1) ( Fig. 4g-o) . These results attest to the low prevalence of false positives among the genes we estimated as being differentially expressed between immature IHCs and OHCs.
The transcriptomes of perinatal cochlear hair cells and supporting cells have been obtained, but these included a mixture of both OHCs and IHCs 25, 26 . Although cell-type specific transcriptomes of mature IHCs and OHCs, obtained using microarrays, have also been published 30 , we have obtained transcriptomes of these cell types before maturity, during early differentiation. A comparison of genes expressed in differentiating and mature IHCs and OHCs reveals very little overlap ( Fig. 3g and Supplementary Table 4 ): only 5.9% of IHC-enriched and 2% of OHC-enriched genes are differentially expressed at differentiating and mature stages. These include some genes that are characteristic of the mature stage (Vglut3 and Otof in IHCs and Prestin in OHCs) but whose expression is incipient at birth. However, the vast majority of genes that were preferentially expressed in either cell type during differentiation (such as Insm1, Insm2 and Bcl11b in OHCs, and Brip1, Car13 and Fgf8 in IHCs) are not expressed upon maturation and vice versa. Thus a complex transcriptome, involving hundreds of genes, is transiently active during OHC-and IHC-specific differentiation. It is in this genetic context that INSM1 locks the fate of OHCs so that they proceed to differentiate into mature OHCs and not IHCs.
To investigate how INSM1 drives OHC differentiation, we used RNAseq to look for genes that were differentially expressed in differentiating OHCs with and without INSM1 (Insm1 GFP.Cre/+ versus Insm1 GFP.Cre/-) ( Fig. 4a, Extended Data Fig. 6 , Supplementary Table 5 ). We identified between 31 and 331 genes that could be differentially expressed (either upregulated or downregulated) by INSM1 ( Supplementary Tables 6, 7) . We established as cutoff either an FDR-adjusted P < 0.05 (red squares) or, for a less stringent selection, a raw P < 0.01 (green squares 
Comparison of these genes with those normally enriched in OHCs or IHCs ( Fig. 4b-e ), combined with RT-qPCR retesting ( Supplementary  Table 8 ) and ISH ( Fig. 4f-o) , showed that, in OHCs, INSM1 does not activate OHC genes but rather inhibits IHC genes. No upregulated genes were confirmed by RT-qPCR and, of the 22 downregulated genes confirmed, 21 are normally preferentially expressed by IHCs. The enrichment of these genes in wild-type IHCs is similar to their upregulation in OHCs lacking INSM1 ( Fig. 4f , g, Extended Data Table 1 ). By contrast, most genes that are differentially expressed in OHCs versus IHCs were not affected by INSM1. We conclude that INSM1 downregulates a specific subset of IHC-enriched genes in embryonic OHCs; without INSM1, those genes are expressed in embryonic OHCs, nearly half of which transdifferentiate into IHCs. At E18.5, OHCs lacking INSM1 have not upregulated most of the early IHC-specific genes and still express early OHC-specific genes (Fig. 4f) , even though many of these cells will, once differentiated, express all examined features and markers of IHCs and none of OHCs ( Fig. 1e-k, m, Extended Data Fig. 3f ). The small number of early IHCspecific genes (21 of 922, about 2%) that were upregulated in embryonic OHCs lacking INSM1 are likely to represent an early step in the genetic cascade that leads to their complete transformation into IHCs. As oc-HCs expressing these few genes differentiate into IHCs, these genes are likely to be required for IHC differentiation. Hence, in addition to identifying Insm1 as a critical gene for OHC differentiation, our results also identify candidate genes for regulating the specific differentiation of IHCs. Because all OHCs express Insm1, but in its absence fewer than half trans-differentiate into IHCs, we expected two patterns of misexpression by ISH ( Fig. 4g-o) . Some genes (Rprm, Id4, Lrrn1, Car13, Pink1 and Brip1; Fig. 4h -n) were upregulated in all OHCs lacking INSM1, as expected if they were repressed by INSM1. These must include the genes whose disinhibition in the absence of INSM1 renders embryonic OHCs susceptible to the gradient that induces IHC trans-differentiation. Other genes (Fgf8 and Tbx2; Figs. 2d, 4o ) were upregulated only in fewer than half of oc-HCs-presumably those that would trans-differentiate into IHCs. These genes are some of the earliest expressed in IHCs, and are likely to include regulators of IHC differentiation.
Our results reveal homeotic transformation of OHCs into IHCs in the absence of INSM1, identify the genes initially misregulated by ablation of Insm1, and provide a genetic mechanism for differentiation of these two cell types: nascent OHCs transiently express Insm1, which represses (directly or indirectly) a core set of early IHC-specific genes and renders the cells insensitive to an IHC-inducing gradient; this consolidates the fate of OHCs by preventing their trans-differentiation into IHCs.
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MEthodS Ethics and animals. All animal care and procedures were in strict accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and were approved by Northwestern University's Institutional Animal Care and Use Committee (Animal Study Protocols IS00001281 and IS00000593). Mus musculus were used in this study. Animals were of CD1 and C57BL/6 genetic background. Similar numbers of male and female animals were used for all analyses, and these are stated in the manuscript. When sex was undetermined, as in the case of embryos, all the embryos were blindly selected. For embryonic samples, we used animals at E16.5, E17.5 and E18.5. For neonatal animals, the average age was 9.27 ± 5.6 (s.d.) days old. For adult animals, the average age was 34.32 ± 6.3 days old. All tests were performed in mutant and littermate control mice, which were otherwise randomly chosen from the litters. Although the phenotype is obvious, quantifications of nuclear size, ribbon synapse densities, cell densities (Fig. 1, Extended Data Figs. 3, 4 ) and hearing tests (Fig. 1, Extended  Data Figs. 3, 5) were performed without knowledge of genotype. Transcriptomic analyses were carried out by a biostatistician from a core facility with no knowledge of genotype. Generation of the Insm1 floxed allele for conditional ablation. The Insm1 targeting construct was generated using a genomic BAC clone, 439G2, from the mouse 129/SvEv genomic BAC library, RPCI-22. The Insm1 gene, including the coding sequence, 5′ and 3′ UTRs, a 2,790-bp 5′ homologous sequence and a 4,098-bp 3′ homologous sequence, was subcloned into the pL253 vector (IA1-pL253) using recombineering, as described previously 31 . The recombined clone, IA1-pL253, was further modified using recombineering to add a LoxP recombination site immediately downstream of the 5′UTR but before the Kozak sequence. A second Frt-NEO-Frt-LoxP site was recombined immediately downstream of the 3′UTR. The completed targeting vector was sequence verified and sent to the Northwestern Transgenic and Targeted Mutagenesis Laboratory (Chicago, IL) for electroporation into SvEv 129 mouse embryonic stem cells.
Using Q5 High-Fidelity Polymerase with GC Enhancer (NEB Catalog:M0491) and the primers WT: TCTTAGATTCTGCCCTTTCTGACAG; CKO: CCAAGGAGATGACCACGCATAG; and R2: CTCTTGTAGGGCCTCCTGTG, we performed a PCR to identify recombinant clones. Conditions for Thermalcycler were: step 1: 98 °C, 3:00 min; step 2: 98 °C, 0:10 min; step 3: 65 °C, 0:30 min, -1 °C per cycle; step 4: 72 °C, 6:45 min; repeat step 2, 10×; step 5: 98 °C, 0:10 min; step 6: 60 °C, 0:30 min; step 7: 72 °C, 6:45 min, repeat step 5, 25×; step 8: 72 °C, 10:00 min; step 9: 4 °C. Expected sizes for wild-type allele using primers WT to R2 was 6,163 bp. Expected size for recombinant clones using CKO-Reverse was 6,145 bp. We screened a total of 439 clones and identified 5 recombinants.
We further screened these five ES cell clones for recombination upstream of the 5′ LoxP site. DNA from selected recombinant clones was digested with the restriction enzyme SpeI (NEB Cat:R0133) and homologous recombination was confirmed by Southern hybridization. DNA was visualized using a 168-bp radiolabelled probe (as described 6 ). The expected band sizes for wild-type and conditional knockout alleles are 18,162 bp and 14,333 bp, respectively. All five ES clones contained a targeted allele of Insm1.
These clones were used for the generation of mosaic embryos, which were implanted into surrogate mothers by the Northwestern Transgenic and Targeted Mutagenesis Laboratory (Chicago, IL). From one of these clones (B3) we first generated chimeric mice, which were mated to mice expressing the FlpE recombinase (B6-Tg(CAG-FLPe)36 32 to delete the NEO cassette flanked by Frt sites and thus generate mice with a floxed allele of Insm1. Hearing tests. During testing, mice of both sexes aged P25-P31 were anaesthetized with ketamine and xylazine (120 mg/kg and 10 mg/kg, respectively, intraperitoneal (IP)) and their body temperature maintained using a heating blanket. In order to assay OHC function, DPOAEs were recorded using a custom probe equipped with a sensitive microphone (Knowles Electronics, FG-3652-CX). Responses were analysed using Emission Averager (EMAV) 33 . Because the probe can be placed close to the eardrum, sound calibrations in the ear canal of each mouse were performed out to 48 kHz using a chirp stimulus generated in System Response (SysRes) 34 . All signals were generated using a CardDeluxe 24-bit sound card with a sampling rate of 96 kHz. Iso-input functions (f2/f1 = 1.2) at L1 = 50 and L2 = 35 dB were recorded for f2 frequencies between 2 and 47 kHz, thereby covering most of the mouse audiogram. Input-output functions were also acquired for various f2 frequencies (6, 12, 27 kHz), where L1 = L2+10 dB. Thresholds for 2f1-f2 were then calculated and represent the level of f1 that produces a DPOAE of 0 dB. After emission testing, neural responses were measured by collecting ABRs using tone-burst stimuli. The threshold was determined by noting the level at which the ABR waveform disappeared into the noise. For these experiments, sound calibration was obtained using a real pinna coupler 35 .Further details were provided in a previous publication 36 . Tissue collection and preparation. Neonatal mice were killed by decapitation, and cochleae dissected in cold HBSS with calcium and magnesium (Gibco). For embryos, timed pregnant dams were killed by isoflurane overdose followed by cervical dislocation. Their abdomens were opened to expose the uterus, which was dissected in cold HBSS with calcium and magnesium (Gibco); embryos were then collected and their cochleae removed. After dissection, neonatal and embryonic cochleae were processed depending on future use. For immunohistochemistry, embryonic and neonatal cochleae were fixed in 4% paraformaldehyde for 2 h at room temperature. For older tissues (>P20), mice were cardiac-perfused with 4% paraformaldehyde, and cochleae were dissected and post-fixed in 4% paraformaldehyde for 2 h at room temperature. Cochleae from animals older than P5 were decalcified in 10% EDTA, pH 7.4, at 4 °C until needed. Organs of Corti were dissected out from the cochleae into one apical, two middle and one basal sections using a whole-mount surface preparation method 37 . Frozen sections were processed as described 4 . Immunohistochemistry. Whole-mount organ of Corti sections were processed for immunohistochemistry as described previously 38 . Primary antibodies were mouse anti-calmodulin (1:100, C-7055, Sigma Aldridge), goat anti-oncomodulin (1:200, sc-7446, Santa Cruz), rabbit anti-prestin (1:1,000, from J. Zheng, Northwestern University), guinea pig anti-VGLUT3 (1:2,500, from R. Edwards, University of California, San Francisco), mouse anti-CtBP2 (1:400, 612044, BD Biosciences), rabbit anti-myosin7a (1:800, 25-6790, Proteus Biosciences), sheep anti-neuroplastin (1:150, AF7818, R&D Systems), mouse anti-BCL11B (1:400, ab18465, abcam), and goat anti-SOX2 (1:500, sc-17320, Santa Cruz). For BCL11B immune-labelling on whole-mount cochlea, we performed antigen retrieval by incubating samples in 10 mM sodium citrate, pH 6 with 0.25% Triton X-100 for 20 min at 92 °C and cooling for 30 min at room temperature before blocking. For CtBP2 and SOX2 immuno-labelling, samples were prepared using a freeze-thaw method. In brief, organ of Corti sections were incubated in 30% sucrose at room temperature for 20 min, put in -80 °C for 5 min and thawed at room temperature for 20 min; sucrose was rinsed off with PBS before blocking and incubation with primary antibodies at 37 °C overnight. Nuclei were counterstained with 1:1,000 DAPI or 1:2,000 Hoechst 33342. X-gal staining. X-gal staining to detect β-galactosidase expression on sections of Insm2 LacZ embryos was performed as described 39 . Cell proliferation assay. In order to label hair and supporting cells generated from progenitors that proliferated postnatally, neonates were injected twice daily from P0 to P5 with the thymidine analogue 5-ethynyl-2′-deoxyuridine (EdU; 50 mg/kg in sterile saline). EdU incorporation into DNA was detected using Click-iT Plus EdU Alexa Fluor 555 Imaging Kit (Thermo Fisher Scientific) according to the manufacturer's manual. Following EdU detection, the samples were immune-labelled with antibodies as described above. Image acquisition and analysis. We acquired images on either a Nikon A1 or A1R+ Confocal imaging system using a 100× objective. 3D renderings were generated using NIS Elements AR4.60.00 (Nikon) and Imaris X64 8.4.1 (BitPlane) software. Nuclei and ribbon synapses were measured using built-in analysis functions on Imaris. After acquisition, we identically processed image pairs of control and knockout samples. This included adjustment for brightness, contrast and parameters for 3D volume and surface renderings of all images. FACS. For collection of OHCs or IHCs, organs of Corti were dissected from E18.5 embryos (Insm1 GFP.Cre/or Insm1 GFP.Cre/+ ) or P0 neonates (Insm1 GFP.Cre/+ ; Atoh1 A1GFP/+ ;R26R tdTomato/+ ) in ice-cold HBSS with calcium and magnesium (Gibco). A portion of tail from each embryo and neonate was collected for genotyping. Organs of Corti were washed three times in cold 1×PBS and then they were digested in 0.33 U/ml papain, 0.5 mM EDTA and 1 mM l-cystine in EBSS for 10 min at 37 °C, rinsed 3 times in 2% FBS and mechanically dissociated by gentle trituration (~100-150× with a P1000 pipet). Cell suspensions were kept on ice until FACS sorting on a BD FACS Aria 4 flow cytometer through a 100-µm nozzle at speed 2 (<100 events/s). Hair cell populations were collected into RLT buffer (Qiagen, Valencia, CA). RNA was then isolated from cells using Qiagen RNeasy Plus Micro Kit or cells were stored at -80 °C until RNA isolation. Isolated RNA was evaluated for quality and concentration on a BioAnalyzer and stored at -80 °C. qRT-PCR. RT-PCR was performed using either SYBR Green or TaqMan systems. Total RNA was extracted from pools of hair cells collected from E18.5 Insm1 GFP.Cre/-, E18.5 Insm1 GFP.Cre/+ , and P0 Insm1 GFP.Cre/+ ;Atoh1 A1GFP/+ ;R26R tdTomato/+ mice through FACS. RNA was extracted using an RNeasy Plus Micro Kit (Qiagen) according to the manufacturer's instructions. RNA quality was determined with a BioAnalyzer through NUSeq Core Facility, Northwestern University, Chicago, IL.
For SYBR Green qRT-PCR, we used ~3,000 pg total RNA from each hair cell pool for first strand cDNA synthesis using iScript reverse transcription supermix (Bio-Rad) according to the manufacturer's manual. We then performed RT-qPCR with ~200 pg of first strand cDNA using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) in triplicate on a CFX Connect Real-Time PCR Detection System (Bio-Rad) using a 40-cycle protocol.
For TaqMan qRT-PCR, we used 1 µg total RNA from each HC pool for first strand cDNA synthesis using SuperScript VILO cDNA Synthesis Kit with ezDNase
Extended Data Fig. 1 | Generation of a conditional KO allele of Insm1. a, We generated a targeting construct in which the sole exon of Insm1 (green rectangle, with the coding sequence in dark green and the UTRs in light green) has a loxP site (purple triangle) inserted in a poorly conserved area of its 5′UTR and another loxP site downstream of the Insm1 gene. The construct also incorporates a neomycin resistance cassette (NEO, blue) surrounded by Frt sites (red triangles) and a thymidine kinase cassette (HSV-TK; orange), which are used to select for recombination events after gene targeting. b, We screened 439 clones and identified 5 recombinants (1 non-recombinant wild type, B5, and 3 recombinants, B6, E10 and B3, are shown) with PCR using primers indicated in a (arrows). The expected size for the wild-type allele using primers WT to R2 is 6,163 bp. The expected size for recombinant clones using CKO-reverse is 6,145 bp. c, Selected embryonic stem (ES) cell clones were additionally screened for homologous recombination upstream of the first loxP site by Southern blotting after digestion with SpeI and using the 5′ probe indicated in a 6 . Southern blotting was performed twice. The expected band sizes for wildtype and conditional KO alleles are 18,162 bp and 14,333 bp, respectively. From one of these clones (B3) we generated first chimeric mice and then mice with floxed alleles of Insm1 (obtained by crossing the chimaeras with mice expressing the FlpE recombinase (B6-Tg(CAG-FLPe)36, which deleted the NEO cassette flanked by FRT sites). Homozygous Insm1 F/F mice are viable, demonstrating that the loxP insertions do not interfere with the vital functions of Insm1 and hence may be used for its conditional ablation. Co-expression with Cre recombinase generates an Insm1 KO allele lacking its entire coding sequence.
Extended Data Fig. 3 | Conditional ablation of Insm1 in hair cells and spiral ganglia neurons using TgPax2 Cre causes hearing impairment and the appearance of IHC-like cells in place of OHCs. a, b, Hearing thresholds determined by ABRs (a) and DPOAEs (b) of TgPax2 Cre/+ ;Insm1 F/F mice at age P35-P46 (black traces; n = 4, 4 females) and control littermates (red traces; n = 5, 2 males and 3 females). The fact that shifts in ABR threshold are larger than shifts in DPOAE threshold may indicate an additional contribution to hearing impairment of the spiral ganglion neurons lacking INSM1 in TgPax2 Cre/+ ;Insm1 F/F cochlea. c, Despite the prevalence of OHCs with IHC characteristics (oc-IHCs) in TgPax2 Cre/+ ;Insm1 F/F cochleae (46.0 ± 5.64% (mean ± s.d.), n = 3 mice; Fig. 1m , n), these mice have the same density of IHCs (9.87 ± 2.41 cells per 100 µm along the organ of Corti; n = 3) as littermate controls (TgPax2 Cre/+ ;Insm1 F/+ and Insm1 F/F ; 10.54 ± 1.67 cells per 100 µm; n = 3) suggesting that oc-IHCs are not IHCs displaced from the inner to the outer compartment. d, There is no OHC loss in TgPax2 Cre/+ ;Insm1 F/F mice at ~P14-P16. Densities of oc-HCs do not differ between TgPax2 Cre/+ ;Insm1 F/F mice (OHCs and oc-IHCs) and their littermate controls (OHCs only) (29.88 ± 7.45 cells per 100 µm along the organ of Corti of TgPax2 Cre/+ ;Insm1 F/F mice, n = 3; 34.3 ± 6.92 cells per 100 µm in TgPax2 Cre/+ ;Insm1 F/+ and Insm1 F/F littermate controls, n = 3). e, The number of oc-HCs per IHC does not differ between TgPax2 Cre/+ ;Insm1 F/F mice and their littermate controls (3.03 ± 0.25 OHCs plus oc-IHCs per IHC in TgPax2 Cre/+ ;Insm1 F/F mice, n = 3; 3.24 ± 0.21 OHCs per IHC in TgPax2 Cre/+ ;Insm1 F/+ and Insm1 F/F littermate controls, n = 3). Onetailed Student's t-tests were used in c-e, n is number of mice. Statistical significance is defined as P < 0.05. f, Immunofluorescence for the IHCenriched calmodulin (green) and hair cell marker myosin VIIa (white) on whole-mount organs of Corti from mid-cochlear positions at ages ~P14-P16 confirmed that many TgPax2 Cre/+ ;Insm1 F/F oc-HCs had IHC characteristics, in addition to having the flask shape and large nuclei of IHCs (blue, DAPI, marked with asterisks), as well as lacking prestin and expressing VGLUT3 (Fig. 1m ). Scale bars, 10 µm. Biological replicates were used for all experiments and similar immunohistochemistry results obtained from three or more mice per genotype.
Extended Data Fig. 5 | Conditional ablation of Insm1 in hair cells using Gfi1-Cre causes no hearing impairment, and results in only very few oc-IHCs. We generated a conditional knockout of Insm1 in hair cells using Gfi1-Cre, in which the expression of cre recombinase coincided with that of Insm1. a, b, Hearing thresholds determined by ABRs (a) and DPOAEs (b) of Gfi1 Cre/+ ;Insm1 F/F mice at age P30-P35 (black traces; n = 6, 4 males and 2 females) and control littermates (red traces; n = 6; 1 Insm1 F/F , 1 Insm1 F/+ and 4 Gfi1 Cre/+ ;Insm1 F/+ ; 4 males and 2 females). There is no significant difference in ABR and DPOAE thresholds at any frequency tested between Gfi1 Cre/+ ;Insm1 F/F mice and their control littermates. c, Immunohistochemistry in whole-mount organs of Corti from mid-cochlear positions of P34 mice tested for hearing in a, b revealed that Gfi1 Cre/+ ;Insm1 F/F mice had normal IHCs expressing high levels of calmodulin. However, very few oc-HCs also expressed calmodulin at high levels, oncomodulin at low levels, and had a round, flask shape similar to that of IHCs (0.78%; 5/526 OHCs from 2 mice). Because in these Gfi1 Cre/+ ;Insm1 F/F mice the onset of Cre recombinase expression coincides with that of Insm1 (E15.5-E17.5) 43 , their nascent OHCs will express Insm1 for at least several hours. This result indicates that brief expression of Insm1 is sufficient to promote proper OHC differentiation. Scale bars, 10 µm. Biological replicates were used for all experiments and similar immunohistochemistry results obtained from three or more mice per genotype.
Extended data table 1 | Confirmed genes misregulated in ohCs lacking INSM1
Differential expression of IHCs with respect to OHCs and of OHCs without INSM1 (from Insm1 GFP.Cre/mice, referred to as KO) with respect to OHCs with INSM1 (from Insm1 GFP.Cre/+ , referred to as Het). Differential expression between KO and Het OHCs estimated by RNA-seq was confirmed by TaqMan RT-qPCR (n = 5 pools of OHCs per genotype for Tbx2, Nhs, Lrrn1, Brip1 and Rin3; n = 4 for all other genes). P values are for one-tailed t-tests on RT-qPCR values. All 22 genes increase their expression in OHCs lacking INSM1. Of these, all except Sez6l are normally preferentially expressed in IHCs. Note that for Id4, differential expression between IHCs and OHCs was not detected by RNA-seq at P0, and it did not reach significance between KO and HET OHCs by RT-qPCR at E18.5. However, significance was achieved (P = 0.013) at E16.5, at which time differential expression was confirmed and visualized by RNAscope in situ hybridization (Fig. 4j ). Hence, for Id4 the differential expression occurs transiently and very early. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
Hearing data were collected using System Response (SysRes) (Neely et al., 2005, Tech. Memo. 19, Boys Town, Nat. Res. Hosp.). Images were acquired using either a Nikon A1 or A1R+ Confocal imaging system with NIS Elements AR4.60.00 software. Flow Cytometry data was collected using BD FACSDiva Version 8.0. qRT-PCR data were collected using either a CFX ConnectTM Real-Time PCR Detection System (Bio-rad) or QuantStudioTM 7 flex Real-Time system (Applied Biosystems). RNA-seq data were obtained using either a Illumina HiSeq2000 sequencing system (Illumina) or Illumina HiSeq4000 sequencing system (Illumina).
